Literature DB >> 30040434

Medication Adherence Among Children and Adolescents with Severe Mental Illness: A Systematic Review and Meta-Analysis.

Juliet Beni Edgcomb1, Bonnie Zima2.   

Abstract

OBJECTIVE: To perform a systematic review and meta-analysis of studies investigating predictors of medication adherence in children and adolescents with severe mental illness (SMI).
METHOD: A systematic literature search was conducted in PubMed/MEDLINE, Web of Science, and PsycINFO from 1980 through October 1st, 2017, for original peer-reviewed articles that investigated predictors of adherence to psychopharmacologic treatment among children (≤18-years-old) with a primary psychotic disorder, bipolar disorder, depression, recent suicide attempt, or psychiatric hospitalization. Effect sizes (ESs) for individual predictors were extracted and combined using DerSimonian-Laird random-effects meta-analysis. Meta-regression and moderator analyses were conducted to investigate subgroups. This review complied with Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines.
RESULTS: A total of 28 studies (n = 180,870) met inclusion criteria; 65.9% (±20.9%) of children and adolescents with SMI were medication adherent. Adherence was associated with patient and family attitudes toward care, adherence to psychotherapy, and insight. Nonadherence was associated with illness severity, substance use, and attention-deficit/hyperactivity disorder. Heterogeneity was moderate-to-large for most ES estimates (I2 > 50%). Age, sex, underlying diagnosis, and study methodology emerged as significant moderators.
CONCLUSION: Medication nonadherence among youth with SMI is highly prevalent. Children and adolescents with more severe illness and higher comorbidity burden are at greater risk for nonadherence. Positive interpersonal care processes and adherence to nonpharmacological treatment may be protective. These findings inform development of a risk profile for nonadherence among youth with SMI. Future prospective research is needed to address the shortcomings in the existing literature and inform interventions to improve adherence.

Entities:  

Keywords:  adolescent; child; medication adherence; mood disorders; psychotic disorders

Mesh:

Year:  2018        PMID: 30040434     DOI: 10.1089/cap.2018.0040

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Self-Report for Measuring and Predicting Medication Adherence: Experts' Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics.

Authors:  Carlos De Las Cuevas; Jose de Leon
Journal:  Patient Prefer Adherence       Date:  2020-10-09       Impact factor: 2.711

2.  Longitudinal course and risk factors associated with psychosis in bipolar youths.

Authors:  Amit Shalev; John Merranko; Mary Kay Gill; Tina Goldstein; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Neal Ryan; Michael Strober; Satish Iyengar; Martin Keller; Shirley Yen; Lauren M Weinstock; David Axelson; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-12-17       Impact factor: 6.744

3.  Perceptions and Experiences of Adolescents with Mental Disorders and Their Parents about Psychotropic Medications in Turkey: A Qualitative Study.

Authors:  Gül Dikec; Cansın Kardelen; Laura Pilz González; Marjan Mohammadzadeh; Öznur Bilaç; Christiane Stock
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

4.  Anxiety, depression, and stress in caregivers of children and adolescents with mental disorders in Ghana and implications for medication adherence.

Authors:  Patience Me Ocansey; Irene A Kretchy; Genevieve C Aryeetey; Kofi Agyabeng; Justice Nonvignon
Journal:  Ghana Med J       Date:  2021-09

5.  Electroconvulsive therapy efficacy in adolescents with mental illness: A retrospective comparison.

Authors:  Qi Si; Xinyue Zhang; Jiaxi Lei; Congxin Chen; Fangfang Ren; Guoxin Xu; Yuan Li; Yuxiu Sui
Journal:  Front Psychiatry       Date:  2022-09-09       Impact factor: 5.435

6.  Treatment Refractory Internalizing Behaviour Across Disorders: An Aetiological Model for Severe Emotion Dysregulation in Adolescence.

Authors:  Pierre C M Herpers; Josephine E C Neumann; Wouter G Staal
Journal:  Child Psychiatry Hum Dev       Date:  2020-08-03

Review 7.  Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.

Authors:  Edward Chesney; Dominic Oliver; Philip McGuire
Journal:  Psychopharmacology (Berl)       Date:  2021-07-13       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.